Back
Corcept Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
CORT
Corcept Therapeutics, Inc.
Last Price:
$70.27
Seasonality Move:
6.8%
7 Day Trial
ALL ACCESS PASS
$
7
Corcept Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Corcept Therapeutics, Inc. has on average historically risen by 36% based on the past 21 years of stock performance.
-
Corcept Therapeutics, Inc. has risen higher in 13 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.9%
-
Is Corcept Therapeutics, Inc. Stock Undervalued?The current Corcept Therapeutics, Inc. [CORT] share price is $70.20. The Score for CORT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
CORT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Corcept Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Corcept Therapeutics, Inc. has on average historically risen by 36% based on the past 21 years of stock performance.
Corcept Therapeutics, Inc. Stock Rating
Sell
36
Corcept Therapeutics, Inc. (CORT)
is a Sell
Is Corcept Therapeutics, Inc. overpriced?
-
Corcept Therapeutics, Inc. has risen higher in 13 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.9%
Corcept Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
corcept.com
52-Week Data
52-Week High:
117.33
52-Week Low:
49.00
Prediction Charts
Market Cap:
7.4B
Price in USD:
70.20
Volume:
2.4M
Beta:
0.76
Technical Analysis
SMA50:
78.49
SMA100:
77.28
SMA200:
74.04
52-Wk Change:
38.04%
Stock Predictions
-
Is Corcept Therapeutics, Inc. stock public?Yes, Corcept Therapeutics, Inc. is a publicly traded company.
-
What is the Corcept Therapeutics, Inc. stock quote today?The Corcept Therapeutics, Inc. stock price is 70.20 USD today.
-
How to buy Corcept Therapeutics, Inc. stock online?You can buy Corcept Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-10 | 83.65 | 85.31 | 85.99 | 82.72 |
| Dec-11 | 85.33 | 87.13 | 87.50 | 85.06 |
| Dec-12 | 87.23 | 87.99 | 88.73 | 86.13 |
| Dec-15 | 88.74 | 87.30 | 89.00 | 87.11 |
| Dec-16 | 86.02 | 81.12 | 86.58 | 78.07 |
| Dec-17 | 81.19 | 82.28 | 82.98 | 79.02 |
| Dec-18 | 82.28 | 81.54 | 83.37 | 81.01 |
| Dec-19 | 82.00 | 83.76 | 85.34 | 81.26 |
| Dec-22 | 84.37 | 85.11 | 85.28 | 83.05 |
| Dec-23 | 84.40 | 81.99 | 85.16 | 80.38 |
| Dec-24 | 82.01 | 83.59 | 84.48 | 81.97 |
| Dec-26 | 83.41 | 82.65 | 83.70 | 82.13 |
| Dec-29 | 82.32 | 79.82 | 82.98 | 79.67 |
| Dec-30 | 79.75 | 70.20 | 79.75 | 69.91 |
Corcept Therapeutics, Inc. Earnings
Corcept Therapeutics, Inc. Earnings Report: Per Share Corcept Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Corcept Therapeutics, Inc. Forecast Revenue Growth
Corcept Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Corcept Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and an increase next year of $3.11 per share.
* Corcept Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.